BFRG Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $20,250.00
Insider Selling (Last 12 Months): $537,447.84

Bullfrog AI Insider Trading History Chart

This chart shows the insider buying and selling history at Bullfrog AI by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Bullfrog AI Share Price & Price History

Current Price: $3.04
Price Change: Price Increase of +0.13 (4.47%)
As of 04/29/2024 11:45 AM ET

This chart shows the closing price history over time for BFRG up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Bullfrog AI Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/1/2024Vininder SinghCEOSell43,056$2.99$128,737.442,549,390View SEC Filing Icon  
1/22/2024Vininder SinghCEOSell25,000$7.50$187,500.002,597,294View SEC Filing Icon  
1/16/2024Vininder SinghCEOSell8,516$2.55$21,715.802,647,294View SEC Filing Icon  
1/12/2024Vininder SinghCEOSell1,515$2.56$3,878.402,655,810View SEC Filing Icon  
1/10/2024Vininder SinghCEOSell4,780$2.75$13,145.002,662,985View SEC Filing Icon  
1/8/2024Vininder SinghCEOSell5,184$2.88$14,929.922,670,909View SEC Filing Icon  
1/5/2024Vininder SinghCEOSell2,644$2.90$7,667.602,676,093View SEC Filing Icon  
1/3/2024Vininder SinghCEOSell5,676$2.18$12,373.682,682,306View SEC Filing Icon  
9/5/2023Vininder SinghCEOSell50,000$2.95$147,500.002,692,446View SEC Filing Icon  
6/14/2023William EnrightDirectorBuy5,000$4.05$20,250.005,000View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Bullfrog AI (NASDAQ:BFRG)

0.96% of Bullfrog AI stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Bullfrog AI logo
Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.
Read More on Bullfrog AI

Today's Range

Now: $3.04
Low: $2.92
High: $3.11

50 Day Range

MA: $3.61
Low: $2.70
High: $5.14

52 Week Range

Now: $3.04
Low: $2.36
High: $8.35

Volume

39,345 shs

Average Volume

2,040,456 shs

Market Capitalization

$23.86 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.49

Who are the company insiders with the largest holdings of Bullfrog AI?

Bullfrog AI's top insider shareholders include:
  1. Vininder Singh (CEO)
  2. William Enright (Director)
Learn More about top insider investors at Bullfrog AI.